Substance Abuse Treatment United States

Authored by Pin Ng

Edited by Alexander Bentley

Reviewed by Michael Por

Substance Abuse Treatment United States

The number of clients in U.S. substance abuse treatment facilities in the last 10 years:

This statistic displays the total number of clients in U.S. substance abuse treatment facilities from 2010 to 2020. In 2019, there were 1,460,706 clients in local, county, or community government run substance abuse treatment facilities.

Number of substance abuse treatment facility clients in the U.S. 2007-2020
Total number of clients in U.S. substance abuse treatment facilities U.S. from 2007 to 2020
2007* 1,135,425
2009 1,182,077
2011 1,224,127
2013 1,249,629
2015 1,305,647
2017 1,356,015
2020 1,460,706

Number of Substance Abuse United States Treatment Facilities

Number of substance abuse united states treatment facilities
Number of substance abuse inited states treatment facilities
Alabama 153
Alaska 96
Arizona 446
Arkansas 167
California 1,797
Colorado 408
Connecticut 220
Delaware 44
District of Columbia 26
Florida 725
Georgia 358
Hawaii 167
Idaho 124
Illinois 775
Indiana 393
Iowa 187
Kansas 179
Kentucky 449
Louisiana 146
Maine 186
Maryland 431
Massachusetts 438
Michigan 467
Minnesota 403
Mississippi 110
Missouri 281
Montana 88
Nebraska 131
Nevada 106
New Hampshire 80
New Jersey 370
New Mexico 166
New York 925
North Carolina 552
North Dakota 85
Ohio 554
Oklahoma 208
Oregon 234
Pennsylvania 600
Puerto Rico 97
Rhode Island 59
South Carolina 121
South Dakota 59
Tennessee 313
Texas 512
Utah 310
Vermont 48
Virginia 254
Washington 452
West Virginia 116
Wisconsin 276
Wyoming 57

Number of substance abuse treatment United States clients receiving methadone

This statistic displays the number of substance abuse treatment clients receiving methadone in the United States from 2007 to 2019. In 2019, there were 408,550 clients receiving methadone under substance abuse treatment facilities. Methadone is a synthetic opioid that is used for pain medication and maintenance therapies.

Number of substance abuse treatment methadone clients in the U.S. 2007-2019

Number of substance abuse treatment clients receiving methadone in the U.S. from 2007 to 2019
2007* 262,684
2009 283,177
2011 306,440
2013 330,308
2015 356,843
2017 382,867
2019 408,550

Suicide thoughts among U.S. adults by substance dependence

This statistic shows suicide thoughts, plans and attempts among adults in the United States as of 2019, sorted by substance dependence or abuse. Around 17 percent of respondents with a drug/alcohol dependence or abuse had serious thoughts of suicide during the past year.

Suicide thoughts among U.S. adults by substance dependence or abuse 2019

Suicide thoughts, plans and attempts among U.S. adults as of 2019, by substance dependence or abuse*
Drug or alcoholic dependence or abuse No drug or dependence or abuse
Had serious thoughts of suicide 17.4 3.8 in %
Made any suicide plans 5.5 1 in %
Attempted suicide 2.3 0.4 in %

Substance abuse treatment United States - Statistics & Facts

The United States continues to cope with drug use among adults and adolescents, with the ongoing opioid epidemic a reminder of the dangers of substance abuse and the damage to individuals and society that it can cause. In recent decades, policies have focused increasingly on the treatment of such abuse instead of on punishment, with treatment programs and facilities becoming the accepted means of tackling addiction. There are many types of substance abuse treatments and rehabilitation programs and facilities in the United States for various substance abuse and addiction problems. Treatment for substance abuse disorder can involve individual or group counseling, the use of medication, outpatient treatment, short-term residential treatment, or long-term residential treatment. In 2018, there were 14,809 substance abuse facilities in the U.S., with the highest number found in the state of California.

In the U.S., around 83 percent of all substance abuse treatment facilities offer outpatient treatment and 24 percent offer long-term residential treatment. An estimated 25 percent of facilities have programs specifically tailored for adolescents, 19 percent have special programs for veterans and 20 percent offer programs for LGBT clients. There were over 1.35 million clients at substance abuse treatment facilities in the U.S. in 2017, a large portion of whom had diagnosed co-occurring mental and substance abuse disorders.

Substance abuse treatment has become a business in the United States, with organizations operating multiple facilities in numerous states. American Addiction Centers, one of the largest treatment organizations in the U.S., reported revenue of almost 296 million dollars in 2018, a substantial increase from the 212 million dollars reported in 2015. In addition, the Hazelden Betty Ford Foundation served a total of 25,495 patients in 2019, compared to 12,366 in 2011.

Number of substance abuse treatment facilities in the U.S. as of 2019, by facility size

This statistic displays the number of substance abuse treatment facilities in the United States by facility size, as of March 2019. There were 2,715 substance abuse treatment facilities in the United States with 15 to 29 clients.

Number of substance abuse treatment facilities in the U.S. by size 2019

Number of substance abuse treatment facilities in the U.S. as of 2019, by facility size*
Fewer than 15 4,182
15 to 29 2,715
30 to 59 2,494
60 to 119 2,263
120 or more 3,185

 

Locations where U.S. adults received treatment for alcohol use in 2019

This survey shows the locations where people in the U.S. received treatment for alcohol use in 2019. It was found that 53 percent of those who received treatment for alcohol use did so through a self-help group.

Places where people in the U.S. received treatment for alcohol use 2019

Locations where U.S. adults received treatment for alcohol use in 2019
Hospital – inpatient 14.8 in %
Rehabilitation facility – inpatient 21.5 in %
Rehabilitation facility – outpatient 35.2 in %
Mental health center – outpatient 29 in %
Emergency room 9.6 in %
Private doctor’s office 19.5 in %
Self-help group 53.2 in %
Prison/jail 5.3 in %

Number of U.S. substance abuse treatment clients under 18 years of age

This statistic displays the number of substance abuse treatment clients under the age of 18 in the United States from 2007 to 2019. In 2019, there were 59,854 non-adult clients in treatment from substance abuse.

Number of substance abuse treatment non-adult clients in the U.S. 2007-2019

Number of U.S. substance abuse treatment clients under 18 years of age from 2007 to 2019
2007 85,518
2009 84,326
2011 82,532
2013 78,156
2015 72,977
2017 62,862
2019 59,854

Revenue of Hazelden Betty Ford Foundation from 2013 to 2019

This statistic shows the annual revenue of the Hazelden Betty Ford Foundation in the U.S. from 2013 to 2019, in thousand U.S. dollars. In 2019, the Hazelden Betty Ford Foundation reported a total operating revenue of over 198 million dollars.

Hazelden Betty Ford Foundation revenue 2013-2019

Revenue of Hazelden Betty Ford Foundation from 2013 to 2019 (in 1,000 U.S. dollars)
2013 2014 2015 2016 2017 2018 2019
Patient service revenue, net 112,396 145,669 149,728 136,824 139,193 154,347 157,612
Total operating revenue 142,778 179,543 183,233 171,037 173,975 191,336 198,471

Annual revenue of American Addiction Centers 2011-2018

This statistic shows the annual revenue of American Addiction Centers, one of the largest substance abuse treatment companies in the U.S., from 2011 to 2018, in thousand U.S. dollars. In 2018, American Addiction Centers reported revenue of almost 296 million dollars.

Annual revenue of American Addiction Centers 2011-2018

American Addiction Centers’ annual revenue from 2011 to 2018 (in 1,000 U.S. dollars)
2011 28,275
2012 66,035
2013 115,741
2014 132,968
2015 212,261
2016 279,770
2017 317,641
2018 295,763

Mental health and substance abuse problems during COVID-19 in the U.S. in June 2020

From June 24 to June 30, 2020, around 40.9 percent of adults aged 18 years or older in the U.S. reported having one or more adverse mental or behavioral health symptoms during the COVID-19 pandemic. This statistic illustrates the percentage of U.S. adults who reported adverse mental health symptoms, increased substance use, and suicidal ideation during COVID-19 pandemic from June 24 to 30, 2020.

Mental health and substance abuse problems during COVID-19 in the U.S. in June 2020

Percentage of U.S. adults with adverse mental health symptoms, increased substance use, or suicidal ideation during the COVID-19 pandemic from June 24 to 30, 2020
Started or increased substance use to cope with pandemic-related stressor emotions* 13.3 in %
Seriously considered suicide in past 30 days 10.7 in %
One or more adverse mental or behavioral health symptom 40.9 in %

Substance Abuse Treatment United States - Opioid use in the U.S. - Statistics & Facts

Opioids are narcotic drugs that affect the nervous system and act as a pain reliever. They include synthetic or partly synthetic drugs that mimic opiates, such as heroin. Common prescription opioids include codeine, fentanyl, hydrocodone, morphine and oxycodone. While opioids are a common and effective method of treating severe and chronic pain, long term use and abuse can lead to addiction, physical dependence and withdrawal symptoms. Opioids are some of the most commonly abused drugs worldwide, with user numbers exceeding those of cocaine and ecstasy.

An Opiate epidemic?

Over the last decade, the United States has seen an increase in deaths related to heroin and prescription opioid abuse. Although these numbers have decreased in recent years, deaths due heroin and prescription opioid abuse remain real problems, while the introduction of new synthetic opioids such as fentanyl have compounded the problem of opioid abuse in the U.S. The spike in the use of heroin and abuse of prescription opioids along with the rise of new synthetic opioids has led many to claim that the U.S. is currently going through an opioid epidemic. Access to cheap heroin and the ease of receiving prescriptions for opioids have been seen as causes of the epidemic. The similarity between heroin and opioids also encourages addicts to use these two drugs as alternatives for each other; when an opioid addict finds it difficult to receive a prescription for opioids, heroin can provide a cheap and accessible alternative.

Heroin use

A recent survey from 2019 found 16.1 percent of individuals 12 years and older in the U.S. felt it was easy to obtain heroin, compared to 17.5 percent in 2016. Although the dangers of heroin use are well known, the number of people who consumed heroin increased over the past decade, reaching a high of 948,000 people in 2016. However, this number has decreased in recent years with an estimated 745,000 people in the U.S. consuming heroin in 2019. It is estimated that around 376,000 adults aged 26 years and older in the United States are currently dependent on or abuse heroin.

Opioid deaths

An increase in overdose deaths in the last decade has been the main feature of the opioid epidemic. In 2019, there were 49,860 overdose deaths in the United States involving opioids, the highest number ever recorded. Opioid use is widespread across the United States, but disproportionately affects certain states, with the states of West Virginia, Delaware, and Maryland currently reporting the highest death rates for opioid overdose. Although deaths due to heroin and prescription opioids have decreased in recent years, deaths from fentanyl, an extremely potent synthetic opioid, continue to increase. In 2019, fentanyl alone caused 36,359 overdose deaths in the United States.

Number of patients with at least one opioid prescription in the U.S. from 2014 to 2018

This statistic depicts the estimates of the total annual number of patients with at least one opioid prescription in the U.S. from 2014 to 2018. Overall, almost 56.8 million patients were estimated being prescribed opioids at least once during 2017. The number dropped down to 49.5 million in 2018.

Number of patients with at least one opioid prescription U.S. 2014-2018

Number of patients with at least one opioid prescription in the U.S. from 2014 to 2018
2014 65,816,625
2015 64,950,261
2016 61,862,364
2017 56,778,428
2018 49,515,948

Number of overdose deaths from prescription opioids in the U.S. from 1999 to 2019, by gender

This statistic presents the number of overdose deaths from prescription opioids in the U.S. from 1999 to 2019, by gender. In 2019, there were an estimated 14,139 overdose deaths in the U.S. from prescription opioids, 5,755 of which occurred among females.

Number of prescription opioid overdose deaths U.S. 1999-2019, by gender

Number of overdose deaths from prescription opioids in the U.S. from 1999 to 2019, by gender
Male Female
1999 2,420 1,022
2000 2,549 1,236
2001 3,162 1,608
2002 4,179 2,304
2003 4,780 2,681
2004 5,433 3,144
2005 6,040 3,572
2006 7,315 4,274
2007 7,933 4,863
2008 8,190 4,959
2009 8,311 5,212
2010 8,939 5,644
2011 9,058 6,082
2012 8,245 5,995
2013 8,096 6,049
2014 8,332 6,506
2015 8,617 6,664
2016 9,978 7,109
2017 9,873 7,156
2018 8,723 6,252
2019 8,384 5,755

Substance Abuse Treatment United States

Number of overdose deaths from fentanyl in the U.S. from 1999 to 2019, by gender

This statistic presents the number of overdose deaths from fentanyl in the U.S. from 1999 to 2019, by gender. In 2019, there were an estimated 36,359 overdose deaths in the U.S. from fentanyl, around 26,283 of which occurred among male.

Number of fentanyl overdose deaths U.S. 1999-2019, by gender

Number of overdose deaths from fentanyl in the U.S. from 1999 to 2019, by gender
Female Male
1999 330 400
2000 374 408
2001 447 510
2002 614 681
2003 643 757
2004 798 866
2005 823 919
2006 1,030 1,677
2007 1,053 1,160
2008 1,083 1,223
2009 1,445 1,501
2010 1,440 1,567
2011 1,247 1,419
2012 1,195 1,433
2013 1,431 1,674
2014 2,079 3,465
2015 3,020 6,560
2016 5,578 13,835
2017 7,942 20,524
2018 8,807 22,528
2019 10,076 26,283

Rate of emergency department visits for nonfatal opioid overdoses in the United States in 2016 and 2017, by gender

In the United States, the rate of emergency department visits for nonfatal opioid overdoses among males increased from 107.5 per 100,000 population in 2016 to 112.6 per 100,000 population in 2017. This statistic shows the rate of emergency department visits for nonfatal opioid overdoses in the United States in 2016 and 2017, by gender.

U.S. emergency department visits for nonfatal opioid overdoses, 2016-2017, by gender

Rate of emergency department visits for nonfatal opioid overdoses in the United States in 2016 and 2017, by gender (per 100,000 population)
2016 2017
All 90.2 93
Male 107.5 112.6
Female 72.5 73.1

Potential fentanyl profitability compared to heroin in the U.S. as of 2017

Fentanyl is a synthetic opioid used particularly in the treatment of pain in cancer patients. It is most commonly administered using a patch directly applied to the skin. It is believed to be 100 times more potent than morphine. It is often sold as a heroin-like substance to recreational opioid users. As of 2017, the price of 1 kg of pure fentanyl for a drug trafficking organization (DTO) was about 4,150 U.S. dollars. Comparatively, heroin sold to DTOs for about 6,000 U.S. dollars. The revenue generated from 1 kg of fentanyl by a DTO is estimated to equal about 1.6 million U.S. dollars.

Heroin Pure Fentanyl
Cost per 1 kg to DTO in USD* 6,000 4,150
Approximate number of kgs produced from original drug procurement** 1 20
Wholesale price per kg in Massachusetts in USD 80,000 80,000
Revenue to DTO in USD from 1 kg*** 80,000 1,600,000

 

Previous: The Holistic Sanctuary

Next: The Wave Clinic

Website | + posts

Alexander Bentley is the CEO of Worlds Best Rehab Magazine™ as well as the creator & pioneer behind Remedy Wellbeing Hotels & Retreats and Tripnotherapy™, embracing ‘NextGen’ psychedelic bio-pharmaceuticals to treat burnout, addiction, depression, anxiety and psychological unease.

Under his leadership as CEO, Remedy Wellbeing Hotels™ received the accolade of Overall Winner: International Wellness Hotel of the Year 2022 by International Rehabs. Because of his incredible work, the individual luxury hotel retreats are the world’s first $1 million-plus exclusive wellness centers providing an escape for individuals and families requiring absolute discretion such as Celebrities, Sportspeople, Executives, Royalty, Entrepreneurs and those subject to intense media scrutiny.

We strive to provide the most up-to-date and accurate information on the web so our readers can make informed decisions about their healthcare. Our subject matter experts specialize in addiction treatment and behavioral healthcare. We follow strict guidelines when fact-checking information and only use credible sources when citing statistics and medical information. Look for the badge Worlds Best Rehab on our articles for the most up-to-date and accurate information. on our articles for the most up-to-date and accurate information. If you feel that any of our content is inaccurate or out-of-date, please let us know via our Contact Page

Disclaimer: We use fact-based content and publish material that is researched, cited, edited, and reviewed by professionals. The information we publish is not intended to be a substitute for professional medical advice, diagnosis or treatment. It should not be used in place of the advice of your physician or another qualified healthcare provider. In a Medical Emergency contact the Emergency Services Immediately.

Worlds Best Rehab is an independent, third-party resource. It does not endorse any particular treatment provider and does not guarantee the quality of treatment services of featured providers.